Compared to Hospice Care, Community Based Peers
Total spending distribution among 8 providers in this specialty
P25MedianP75P90
This provider's total spending of $22.1M is at the 25th percentile among 8 Hospice Care, Community Based providers.
Active Billing Period:2018-01→2024-11(83 months)
Extreme procedure concentration — 100% of $22.1M billed through a single code
Total Paid
$22.1M
$22,071,276
Total Claims
5,158
Beneficiaries
3,664
1.4 claims/patient
Avg Cost/Claim
$4K
Monthly Spending Trend
Yearly Spending
2018
$3.2M
-19%
2019
$2.6M
-2%
2020
$2.5M
-4%
2021
$2.4M
+40%
2022
$3.4M
+11%
2023
$3.8M
+9%
2024
$4.1M
Procedure Breakdown
Cost per claim compared to national benchmarks
This provider bills for 1 distinct procedure code. The top code (Q5003 (Injection, infliximab-dyyb, biosimilar, 10 mg)) accounts for 100% of total spending.
ProcedureTotalYour Cost/ClaimNational Medianvs MedianPercentile
$22.1M
5,158 claims
$4,279.04
$177.99
24.0×
Top 10%
Q5003Top 10%
Injection, infliximab-dyyb, biosimilar, 10 mg
$22.1M
5,158 claims · 100.0%
Your Cost: $4,279.04/claim|Median: $177.99
24.0× medianOther Top Providers in Maryland
View all →Similar Providers
Other top providers in Hospice Care, Community Based